Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2003
09/18/2003CA2478089A1 Methods and composition based on discovery of metabolism of nitroclycerin
09/18/2003CA2478087A1 Microtubule stabilizing compounds
09/18/2003CA2478065A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003CA2478028A1 Benzimidazole-derivatives for the treatment of sexual dysfunction
09/18/2003CA2478026A1 Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline
09/18/2003CA2477984A1 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/18/2003CA2477982A1 Methods for entrapment of bioactive agent in a liposome or lipid complex
09/18/2003CA2477979A1 An inhalation system for treatment of intracellular infections
09/18/2003CA2477973A1 Methods for alzheimer's disease treatment and cognitive enhancement
09/18/2003CA2477949A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/18/2003CA2477932A1 Use of egfr transactivation inhibitors in human cancer
09/18/2003CA2477780A1 Methods of enhancing immune induction involving mda-7
09/18/2003CA2477701A1 Controlled release dosage forms
09/18/2003CA2477393A1 Ibuprofen solution for hard shell capsules
09/18/2003CA2477329A1 Controlled delivery patch of active ingredient
09/18/2003CA2476031A1 Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
09/18/2003CA2475738A1 Activated protein c formulations
09/18/2003CA2474771A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
09/18/2003CA2474613A1 Sustained release drug formulations containing a carrier peptide
09/18/2003CA2459834A1 Citalopram for the treatment of elevated blood pressure
09/18/2003CA2423259A1 New compounds derived from quinazoline, the process for preparing them, and the pharmaceutical compositions containing them
09/17/2003EP1344779A1 Azolo-pyrimidines
09/17/2003EP1344776A1 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
09/17/2003EP1344773A1 Growth hormone secretagogues
09/17/2003EP1344535A2 Combined angiotensin II antagonists and adrenaline receptor blockers for treatment of glaucoma
09/17/2003EP1344534A2 Combined angiotensin II antagonists and carbonic anhydrase inhibitors for treatment of glaucoma
09/17/2003EP1344529A1 Therapeutic compositions for treating male pattern baldness
09/17/2003EP1344528A1 External skin preparations and process for producing the same
09/17/2003EP1344527A1 Preventives or remedies for endometriosis or uterine myoma
09/17/2003EP1344526A1 Preventives/ermedies for inflammatory airway diseases
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1344524A1 Reflux inhibitors
09/17/2003EP1344523A1 Ibuprofen solution for hard gelatin capsules
09/17/2003EP1344522A1 Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
09/17/2003EP1344516A1 Antioxidative composition
09/17/2003EP1344060A2 Process for determining target function and identifying drug leads
09/17/2003EP1343913A2 Antisense modulation of src-2 expression
09/17/2003EP1343912A2 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
09/17/2003EP1343900A2 Oxidoreductases
09/17/2003EP1343893A1 Production of stilbenes in transgenic plants and the method of producing thereof
09/17/2003EP1343888A2 Regulation of human chemokine-like receptor
09/17/2003EP1343884A2 Jfy1 protein induces rapid apoptosis
09/17/2003EP1343860A1 A process for preparing vegetable oil fractions rich in non-tocolic, high-melting, unsaponifiable matter
09/17/2003EP1343826A1 Polysaccharide compound having immune stimulating activity
09/17/2003EP1343817A2 Novel treatment
09/17/2003EP1343807A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
09/17/2003EP1343806A1 Methylene steroids as novel androgens
09/17/2003EP1343805A1 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
09/17/2003EP1343804A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile
09/17/2003EP1343803A2 2-substituted estrogens as antiangiogenic agents
09/17/2003EP1343798A1 6-o-carbamoyl ketolide derivatives of erythromycin useful as antibacterials
09/17/2003EP1343797A1 Macrolide antibiotics
09/17/2003EP1343791A2 Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists
09/17/2003EP1343790A2 Cephalosporin production
09/17/2003EP1343789A1 Tricyclic derivatives of indole with antiangiogenic activity
09/17/2003EP1343788A1 Imidazo-triazine derivatives as ligands for gaba receptors
09/17/2003EP1343786A1 Novel pyridine-substituted pyrazolopyridine derivatives
09/17/2003EP1343784A2 Urea substituted imidazoquinoline ethers
09/17/2003EP1343783A2 Substituted imidazopyridines
09/17/2003EP1343782A1 Pyrimidineamines as angiogenesis modulators
09/17/2003EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/17/2003EP1343780A1 Piperazine derivatives for treatment of bacterial infections
09/17/2003EP1343779A2 Novel compounds
09/17/2003EP1343778A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343774A1 1,1-dioxo-2h-1, 2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compositions comprising same
09/17/2003EP1343773A1 Thiazole derivatives for traeing ppar related disorders
09/17/2003EP1343771A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
09/17/2003EP1343769A1 Benzoylpyridazines
09/17/2003EP1343768A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
09/17/2003EP1343765A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
09/17/2003EP1343764A1 Urea and urethane derivatives as integrin inhibitors
09/17/2003EP1343763A1 Pyrodone derivatives as ap2 inhibitors
09/17/2003EP1343761A1 Piperidine mch antagonists and their use in the treatment of obesity
09/17/2003EP1343760A2 Muscarinic antagonists
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343757A1 Indole derivatives
09/17/2003EP1343756A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343746A1 Carboxylic acid compound having cyclopropane ring
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1343530A1 Oral pharmaceutical composition containing a block copolymer
09/17/2003EP1343529A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
09/17/2003EP1343528A2 Methods for stimulating nervous system regeneration and repair by inhibition phosphodiesterase type 4
09/17/2003EP1343516A2 Analogues of thiocoraline and be-22179
09/17/2003EP1343511A1 Shark meat extract
09/17/2003EP1343510A1 Light stabilized antimicrobial materials
09/17/2003EP1343509A2 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
09/17/2003EP1343508A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
09/17/2003EP1343507A2 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs
09/17/2003EP1343506A1 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343504A2 Pharmaceutical formulation of gepirone for oral administration
09/17/2003EP1343503A1 Heteroaryl urea neuropeptide y y5 receptor antagonists
09/17/2003EP1343502A2 Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
09/17/2003EP1343501A1 Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers
09/17/2003EP1343500A2 Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer
09/17/2003EP1343499A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
09/17/2003EP1343498A1 Novel uses of non-peptide bombesin receptor antagonists for treating anxiety and panic disorders
09/17/2003EP1343497A1 $g(D)?2 ,-1,2,3-TRIAZOLINE ANTICONVULSANTS AND THEIR ACTIVE METABOLITE ANALOGUES, THE AMINOALKYLPYRIDINES, ARE EXCITATORY AMINO ACID ANTAGONISTS AND ANTIISCHEMIC AGENTS, USEFUL IN THE TREATMENT OF CEREBRAL ISCHEMIA RESULTING FROM STROKE
1 ... 5340 5341 5342 5343 5344 5345 5346 5347 5348 5349 5350 5351 5352 5353 5354 5355 5356 5357 5358 5359 5360 ... 7860